Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Virus Research
- Vol. 271, 197677
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
This publication has 34 references indexed in Scilit:
- Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitroAntiviral Research, 2018
- Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeuticsAntiviral Research, 2015
- Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus NucleocapsidsJournal of Virology, 2013
- Selection of chronic hepatitis B therapy with high barrier to resistanceThe Lancet Infectious Diseases, 2012
- Small-Molecule Effectors of Hepatitis B Virus Capsid Assembly Give Insight into Virus Life CycleJournal of Virology, 2008
- ASEDock-Docking Based on Alpha Spheres and Excluded VolumesJournal of Chemical Information and Modeling, 2008
- The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packagingAntiviral Research, 2007
- Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteinsJournal of General Virology, 2003
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003
- Structural organization of the hepatitis B virus minichromosomeJournal of Molecular Biology, 2001